LAMEA Continuous Glucose Monitoring Device Market Size

LAMEA Continuous Glucose Monitoring Device Market Size

LAMEA Continuous Glucose Monitoring Device Market By Component (Sensors, Transmitters, and Receivers) By End User (Hospitals, Homecare Settings and Other End Users) By Country, Industry Analysis and Forecast, 2020 - 2026

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : May-2020 | Number of Pages : 81 | Format : PDF

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Continuous Glucose Monitoring Device Market, by Component
1.4.2 LAMEA Continuous Glucose Monitoring Device Market, by End User
1.4.3 LAMEA Continuous Glucose Monitoring Device Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Continuous Glucose Monitoring Device Market by Component
3.1 LAMEA Sensors Market by Country
3.2 LAMEA Transmitters Market by Country
3.3 LAMEA Receivers Market by Country

Chapter 4. LAMEA Continuous Glucose Monitoring Device Market by End-user
4.1 LAMEA Hospitals Continuous Glucose Monitoring Device Market by Country
4.2 LAMEA Homecare Settings Market by Country
4.3 LAMEA Other End Users Market by Country

Chapter 5. LAMEA Continuous Glucose Monitoring Device Market by Country
5.1 Brazil Continuous Glucose Monitoring Device Market
5.1.1 Brazil Continuous Glucose Monitoring Device Market by Component
5.1.2 Brazil Continuous Glucose Monitoring Device Market by End-user
5.2 Argentina Continuous Glucose Monitoring Device Market
5.2.1 Argentina Continuous Glucose Monitoring Device Market by Component
5.2.2 Argentina Continuous Glucose Monitoring Device Market by End-user
5.3 UAE Continuous Glucose Monitoring Device Market
5.3.1 UAE Continuous Glucose Monitoring Device Market by Component
5.3.2 UAE Continuous Glucose Monitoring Device Market by End-user
5.4 Saudi Arabia Continuous Glucose Monitoring Device Market
5.4.1 Saudi Arabia Continuous Glucose Monitoring Device Market by Component
5.4.2 Saudi Arabia Continuous Glucose Monitoring Device Market by End-user
5.5 South Africa Continuous Glucose Monitoring Device Market
5.5.1 South Africa Continuous Glucose Monitoring Device Market by Component
5.5.2 South Africa Continuous Glucose Monitoring Device Market by End-user
5.6 Nigeria Continuous Glucose Monitoring Device Market
5.6.1 Nigeria Continuous Glucose Monitoring Device Market by Component
5.6.2 Nigeria Continuous Glucose Monitoring Device Market by End-user
5.7 Rest of LAMEA Continuous Glucose Monitoring Device Market
5.7.1 Rest of LAMEA Continuous Glucose Monitoring Device Market by Component
5.7.2 Rest of LAMEA Continuous Glucose Monitoring Device Market by End-user

Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Acquisition and Mergers:
6.2.5.3 Approvals:
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental & Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.5 DexCom, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals:
6.6 Ypsomed AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Senseonics Holdings, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 GlySens, Incorporated
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 A. Menarini Diagnostics Ltd. (The Menarini Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.1 Echo Therapeutics, Inc.
6.10.1 Company Overview
6.11 Johnson and Johnson
6.11.1 Company Overview
6.11.2 Financial Analysis
6.11.3 Segmental &Regional Analysis
6.11.4 Research & Development Expenses
6.11.5 Recent strategies and developments:
6.11.5.1 Approvals:


Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities